Built for the moment when visibility stops being enough.
Mertex builds tightly scoped diagnostic products for PLG B2B SaaS teams. The current flagship is TraceRank: a focused activation decision audit for onboarding and first-value flows.
One clean journey export in. One ranked activation decision out.
Public-safe specimens showing diagnostic method, output structure, and failure-pattern range.
The proof set includes severe and contained activation breakdowns.
Verify, Setup, and Create Account breakdowns are represented.
The Standard Activation Decision Audit is the paid path for teams ready to purchase now.
Private Proof Pilot first. Standard paid audit second.
Qualified PLG B2B SaaS teams can apply for selected no-cost access during the proof pilot window. The standard paid path remains the $1,500 Standard Activation Decision Audit for teams that need the ranked first move now.
Private Proof Pilot
Selected no-cost access for qualified teams while real public-safe proof is being earned.
Standard Activation Decision Audit for teams ready to purchase the diagnostic now.
Tighter products. Clearer proof. Lower-variance claims.
Mertex is built around a narrow operating standard: reduce the decision surface, make the proof inspectable, and avoid inflated claims before the market has earned them.
The long-term direction is not more dashboards. It is a stronger activation decision layer: diagnosis, monitoring, and eventually cross-customer benchmark intelligence.
TraceRank
Focused activation decision audit for PLG B2B SaaS onboarding and first-value flows.
Teams that can already see onboarding friction and still do not know what to fix first.
One journey. One diagnostic pass. One ranked activation decision.
A buyer can inspect the public proof surface before purchase instead of relying on vague claims.
The product is shaped for prioritization, not dashboard sprawl.
© 2026 Ava Davis Studio LLC, doing business as Mertex. All rights reserved.